Selectively T cell-depleted allografts from hla-matched sibling donors followed by low-dose posttransplantation immunosuppression to improve transplantation outcome in patients with hematologic malignancies

Biology of Blood and Marrow Transplantation

Volumn 17, Issue 12, 2011, Pages 1855-1861

  Mielke, Stephan ^a   McIver, Zachariah A ^b   Shenoy, Aarthy ^c   Fellowes, Vicki ^d   Khuu, Hahn ^d   Stroncek, David F ^d   Leitman, Susan F ^d   Childs, Richard ^b   Battiwalla, Minoo ^b   Koklanaris, Eleftheria ^b   Haggerty, Janice ^b   Savani, Bipin N ^e   Rezvani, Katie ^f   Barrett, A John ^b  

^a UNIVERSITY HOSPITAL WÜRZBURG   (Germany)

^b NATIONAL HEART LUNG AND BLOOD INSTITUTE   (United States)

^c WASHINGTON HOSPITAL CENTER   (United States)

^d NATIONAL INSTITUTES OF HEALTH   (United States)

^e VANDERBILT UNIVERSITY MEDICAL CENTER   (United States)

^f HAMMERSMITH HOSPITAL   (United Kingdom)

Author keywords

Acute GVHD; Allogeneic; Selective depletion; Transplantation

Indexed keywords

4,5 DIBROMORHODAMINE 123; COTRIMOXAZOLE; CYCLOPHOSPHAMIDE; CYCLOSPORIN A; FLUCONAZOLE; FLUDARABINE; RHODAMINE 123; TH 9402; UNCLASSIFIED DRUG; VALACICLOVIR;

ACUTE GRAFT VERSUS HOST DISEASE; ADULT; AGED; ALLOGENEIC STEM CELL TRANSPLANTATION; ARTICLE; CANCER RELAPSE; CANCER SURVIVAL; CD34 SELECTION; CLINICAL ARTICLE; CLINICAL TRIAL; DISEASE FREE SURVIVAL; EX VIVO STUDY; FEMALE; HEMATOLOGIC MALIGNANCY; HIGH RISK PATIENT; HLA MATCHING; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; IRRADIATION; LOW DRUG DOSE; LYMPHOCYTE DEPLETION; MALE; MIXED LYMPHOCYTE REACTION; OVERALL SURVIVAL; PHOTOSENSITIZATION; RECURRENCE RISK; SIBLING; T LYMPHOCYTE; TREATMENT OUTCOME; WHOLE BODY RADIATION;

ADULT; AGED; DISEASE-FREE SURVIVAL; FEMALE; GRAFT VS HOST DISEASE; HEMATOLOGIC NEOPLASMS; HLA ANTIGENS; HUMANS; LYMPHOCYTE DEPLETION; MALE; MIDDLE AGED; PERIPHERAL BLOOD STEM CELL TRANSPLANTATION; SIBLINGS; T-LYMPHOCYTES; TISSUE DONORS; TRANSPLANTATION, HOMOLOGOUS; YOUNG ADULT;

EID: 80053198764     PISSN: 10838791     EISSN: 15236536     Source Type: Journal    
DOI: 10.1016/j.bbmt.2011.05.019     Document Type: Article

References (17)

1. Dazzi F., Fozza C. Disease relapse after haematopoietic stem cell transplantation: risk factors and treatment. Best Pract Res Clin Haematol 2007, 20:311-327.
2. Mielke S., Solomon S.R., Barrett A.J. Selective depletion strategies in allogeneic stem cell transplantation. Cytotherapy 2005, 7:109-115.
3. Mavroudis D.A., Dermime S., Molldrem J., et al. Specific depletion of alloreactive T cells in HLA-identical siblings: a method for separating graft-versus-host and graft-versus-leukaemia reactions. Br J Haematol 1998, 101:565-570.
4. Michalek J., Collins R.H., Durrani H.P., et al. Definitive separation of graft-versus-leukemia- and graft-versus-host-specific CD4+ T cells by virtue of their receptor beta loci sequences. Proc Natl Acad Sci U S A 2003, 100:1180-1184.
5. Fujiwara H., Sconocchia G., Melenhorst J., et al. Tissue-restricted T cell alloresponses across HLA barriers: selection and identification of leukemia-restricted CTL in HLA-mismatched stimulator-responder pairs. Bone Marrow Transplant 2003, 32:371-378.
6. Andre-Schmutz I., Le Deist F., Hacein-Bey-Abina S., et al. Immune reconstitution without graft-versus-host disease after haemopoietic stem-cell transplantation: a phase 1/2 study. Lancet 2002, 360:130-137.
7. Solomon S.R., Mielke S., Savani B.N., et al. Selective depletion of alloreactive donor lymphocytes: a novel method to reduce the severity of graft-versus-host disease in older patients undergoing matched sibling donor stem cell transplantation. Blood 2005, 106:1123-1129.
8. Amrolia P.J., Muccioli-Casadei G., Huls H., et al. Adoptive immunotherapy with allodepleted donor T-cells improves immune reconstitution after haploidentical stem cell transplantation. Blood 2006, 108:1797-1808.
9. Chen B.J., Cui X., Liu C., et al. Prevention of graft-versus-host disease while preserving graft-versus-leukemia effect after selective depletion of host-reactive T cells by photodynamic cell purging process. Blood 2002, 99:3083-3088.
10. Guimond M., Balassy A., Barrette M., et al. P-glycoprotein targeting: a unique strategy to selectively eliminate immunoreactive T cells. Blood 2002, 100:375-382.
11. Mielke S., Nunes R., Rezvani K., et al. A clinical-scale selective allodepletion approach for the treatment of HLA-mismatched and matched donor-recipient pairs using expanded T lymphocytes as antigen-presenting cells and a TH9402-based photodepletion technique. Blood 2008, 111:4392-4402.
12. Guidelines for Preventing Opportunistic Infections Among Hematopoietic Stem Cell Transplant Recipients: Recommendations of CDC, the Infectious Diseases Society of America, and the American Society of Blood and Marrow Transplantation. Available at: Accessed July 1, 2007. http://www.cdc.gov/mmwr/preview/mmwrhtml/rr4910a1.htm.
13. Glucksberg H., Storb R., Fefer A., et al. Clinical manifestations of graft-versus-host disease in human recipients of marrow from HL-A-matched sibling donors. Transplantation 1974, 18:295-304.
14. Sviland L., Pearson A.D., Eastham E.J., et al. Histological features of skin and rectal biopsy specimens after autologous and allogeneic bone marrow transplantation. J Clin Pathol 1988, 41:148-154.
15. Scheinberg P., Price D.A., Ambrozak D.R., et al. Alloreactive T cell clonotype recruitment in a mixed lymphocyte reaction: implications for graft engineering. Exp Hematol 2006, 34:788-795.
16. Roy D.C., Lachance S., Kiss T., et al. Haploidentical stem cell transplantation: high doses of alloreactive-T cell depleted donor lymphocytes administered post-transplant decreases infections and improve survival without causing severe GVHD. Blood 2009, 112:212.
17. McIver Z., Melenhorst J.J., Grim A., et al. Immune reconstitution in recipients of photodepleted HLA-identical sibling donor stem cell transplants: T cell subset frequencies predict outcome. Biol Blood Marrow Transplant 2011, 17:1846-1854.